Learning From Errors: Response to Gefitinib in Kidney Urothelial Carcinoma With EGFR Mutations

This letter describes the first demonstration of clinical response to the anti-EGFR inhibitor gefitinib in a case of urothelial carcinoma of the renal pelvis harboring a rare EGFR double mutation. New mutations and unexpected clinical responses should be always explored through wide-spectrum mutatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fiorentino, Michelangelo, Giunchi, Francesca, Altimari, Annalisa, Di Tullio, PierGiorgio, Gruppioni, Elisa, Martorana, Giuseppe, Pinto, Carmine
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3983821/
https://ncbi.nlm.nih.gov/pubmed/24652385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0346
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados